OMC
CCXI

Old Mission Capital’s ChemoCentryx, Inc. CCXI Stock Holding History

Old Mission Capital’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-7,717
Closed -$423K – 728
2020
Q3 		$423K Buy
+7,717
New +$415K 0.03% 307

Other funds holding CCXI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Old Mission Capital's CCXI Position: Q4 2020 in Review

Old Mission Capital sold out of ChemoCentryx, Inc. (CCXI) in Q4 2020, closing a stake of 7,717 shares — an estimated $423K sold.

Old Mission Capital first reported a position in CCXI in Q3 2020 and held it in 1 quarter. The position peaked at $423K in Q3 2020. 196 funds tracked by Wall St. Rank hold CCXI as of Q4 2020.

  • Old Mission Capital reported no remaining ChemoCentryx, Inc. position as of Q4 2020 after selling out during the quarter.
  • Old Mission Capital sold 7,717 ChemoCentryx, Inc. shares in Q4 2020, an estimated $423K.
  • Old Mission Capital first reported a position in ChemoCentryx, Inc. in Q3 2020 and held it in 1 quarter.
  • Old Mission Capital's ChemoCentryx, Inc. position peaked at $423K in Q3 2020.
  • 196 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2020.

Based on Old Mission Capital's 13F filing for Q4 2020, filed 17 Feb 2021.